scholarly article | Q13442814 |
P50 | author | Jennifer Mindell | Q40442797 |
Simon Fraser | Q55834851 | ||
P2093 | author name string | Paul J Roderick | |
Donal O'Donoghue | |||
Graham Moon | |||
Grant Aitken | |||
Marilyn Roth | |||
P433 | issue | 4 | |
P921 | main subject | chronic renal insufficiency | Q736715 |
socioeconomics | Q1643441 | ||
P304 | page(s) | 577-586 | |
P577 | publication date | 2013-11-25 | |
P1433 | published in | Journal of Public Health | Q15754594 |
P1476 | title | Chronic kidney disease, albuminuria and socioeconomic status in the Health Surveys for England 2009 and 2010. | |
P478 | volume | 36 |
Q38795283 | A Systematic Review of the Prevalence and Associations of Limited Health Literacy in CKD. |
Q90611528 | Association of urinary albumin excretion with periodontal parameters in patients with type 2 diabetes mellitus: a cross-sectional study |
Q94525951 | BCc1 Nanomedicine Therapeutic Effects in Streptozotocin and High-Fat Diet Induced Diabetic Kidney Disease |
Q40381846 | Chronic kidney disease among adult participants of the ELSA-Brasil cohort: association with race and socioeconomic position. |
Q28066936 | Chronic kidney disease: identification and management in primary care |
Q30240086 | Chronic kidney disease: towards a risk-based approach |
Q47953908 | Decreased serum extracellular superoxide dismutase activity is associated with albuminuria in Chinese patients with type 2 diabetes mellitus. |
Q37369930 | Dietary Energy Density, Renal Function, and Progression of Chronic Kidney Disease |
Q41581182 | Feasibility randomised multicentre, double-blind, double-dummy controlled trial of anakinra, an interleukin-1 receptor antagonist versus intramuscular methylprednisolone for acute gout attacks in patients with chronic kidney disease (ASGARD): protoc |
Q93270543 | High prevalence of albuminuria amongst people who inject drugs: A cross-sectional study |
Q35957666 | Income Related Inequality of Health Care Access in Japan: A Retrospective Cohort Study |
Q37356778 | Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: a systematic review protocol |
Q26799639 | Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review |
Q26783181 | Methods Used in Economic Evaluations of Chronic Kidney Disease Testing - A Systematic Review |
Q41586187 | Socio-economic status influences chronic kidney disease prevalence in primary care: a community-based cross-sectional analysis |
Q64088462 | The association between socioeconomic status and prevalence of chronic kidney disease |
Q91984016 | The association of socioeconomic status with incidence and outcomes of acute kidney injury |
Q42706830 | The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study |
Q38309577 | The impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic review |
Q35097364 | Timeliness in chronic kidney disease and albuminuria identification: a retrospective cohort study |
Q58108164 | Use of an electronic patient-reported outcome measure in the management of patients with advanced chronic kidney disease: the RePROM pilot trial protocol |
Q36734279 | Where now for proteinuria testing in chronic kidney disease?: Good evidence can clarify a potentially confusing message |
Search more.